Adapting a Stress Management Intervention to Reduce Cardiovascular Disease Risk
Adapting and Piloting a Stress Management Intervention to Reduce Cardiovascular Disease Risk Among Women Living With HIV
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
This NA trial investigates Blood Pressure and Cardiovascular Diseases (CVD) and is currently actively recruiting participants. National Heart, Lung, and Blood Institute (NHLBI) leads this study, which shows 3 recorded versions since 2025 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
3 versions recorded-
Sep 2025 — Present [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2025 — Sep 2025 [monthly]
Not Yet Recruiting NA
-
Mar 2025 — May 2025 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Heart, Lung, and Blood Institute (NHLBI)
- University of Alabama at Birmingham
For direct contact, visit the study record on ClinicalTrials.gov .